Evidence map›Paper›PMID 38012191›Full record

ArticleScientific reports2023

Genomic analysis of Plasmodium vivax describes patterns of connectivity and putative drivers of adaptation in Ethiopia.

Alebachew Messele Kebede, Edwin Sutanto, Hidayat Trimarsanto, Ernest Diez Benavente, Mariana Barnes, Richard D Pearson, Sasha V Siegel, Berhanu Erko, Ashenafi Assefa, Sisay Getachew and 13 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 14 institutions in 8 countries.

Alebachew Messele KebedeAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Edwin SutantoExeins Health Initiative, Jakarta, Indonesia.
Hidayat TrimarsantoMenzies School of Health Research and Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia.
Ernest Diez BenaventeLaboratory of Experimental Cardiology, Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Mariana BarnesMenzies School of Health Research and Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia.
Richard D PearsonWellcome Sanger Institute, Hinxton, UK.
Sasha V SiegelWellcome Sanger Institute, Hinxton, UK.
Berhanu ErkoAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Ashenafi AssefaEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Sisay GetachewArmauer Hansen Research Unit (AHRI), Addis Ababa, Ethiopia.
Abraham AseffaArmauer Hansen Research Unit (AHRI), Addis Ababa, Ethiopia.
Beyene PetrosAddis Ababa University, Addis Ababa, Ethiopia.
Eugenia LoDepartment of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, USA.
Rezika MohammedUniversity of Gondar, Gondar, Ethiopia.
Daniel YilmaJimma University Clinical Trial Unit, Department of Internal Medicine, Jimma University, Jimma, Ethiopia.
Angela RumasebMenzies School of Health Research and Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia.
Francois NostenShoklo Malaria Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.
Rintis NoviyantiEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Julian C RaynerCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
Dominic P KwiatkowskiWellcome Sanger Institute, Hinxton, UK.
Ric N PriceMenzies School of Health Research and Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia.
Lemu GolassaAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Sarah AuburnMenzies School of Health Research and Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia. Sarah.Auburn@Menzies.edu.au.
Addis Ababa University · ETWellcome Sanger Institute · GBCharles Darwin University · AUEijkman Institute for Molecular Biology · IDArmauer Hansen Research Institute · ETDrexel University · USEthiopian Public Health Institute · ETJimma University · ETMahidol University · THMenzies School of Health Research · AUUniversity Medical Center Utrecht · NLUniversity of Cambridge · GBUniversity of Gondar · ETUniversity of Oxford · GB

Funding

Medical Research Council M006212Medical Research Council MR/M006212/1Wellcome TrustWellcome Trust 200909Wellcome Trust 206194
6 · The paper itself

Abstract

Ethiopia has the greatest burden of Plasmodium vivax in Africa, but little is known about the epidemiological landscape of parasites across the country. We analysed the genomic diversity of 137 P. vivax isolates collected nine Ethiopian districts from 2012 to 2016. Signatures of selection were detected by cross-country comparisons with isolates from Thailand (n = 104) and Indonesia (n = 111), representing regions with low and high chloroquine resistance respectively. 26% (35/137) of Ethiopian infections were polyclonal, and 48.5% (17/35) of these comprised highly related clones (within-host identity-by-descent > 25%), indicating frequent co-transmission and superinfection. Parasite gene flow between districts could not be explained entirely by geographic distance, with economic and cultural factors hypothesised to have an impact on connectivity. Amplification of the duffy binding protein gene (pvdbp1) was prevalent across all districts (16-75%). Cross-population haplotype homozygosity revealed positive selection in a region proximal to the putative chloroquine resistance transporter gene (pvcrt-o). An S25P variant in amino acid transporter 1 (pvaat1), whose homologue has recently been implicated in P. falciparum chloroquine resistance evolution, was prevalent in Ethiopia (96%) but not Thailand or Indonesia (35-53%). The genomic architecture in Ethiopia highlights circulating variants of potential public health concern in an endemic setting with evidence of stable transmission.

Indexed as

AntimalarialsMalaria, FalciparumMalaria, VivaxChloroquineDrug ResistanceEthiopiaGenomicsHumansPlasmodium falciparumPlasmodium vivaxProtozoan ProteinsAntimalarialsChloroquineProtozoan Proteins

Identifiers

PMID38012191
PMCPMC10682486
OpenAlexW4389049431

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.